UPDATE: Jefferies Downgrades Ventas to Hold, Raises PT on Balance Risk/Reward

In a report published Wednesday, Jefferies analyst Omotayo Okusanya downgraded the rating on Ventas VTR from Buy to Hold, but raised the price target from $78.00 to $82.00. In the report, Okusanya noted, “While VTR remains our favorite large-cap healthcare REIT, the stock's 21% rise YTD has resulted in a full valuation. Coupled with the potential for increased headline risk of new assisted living supply, we downgrade shares to Hold from Buy. That said, we raise our PT to $82 to reflect expectations of significant accretive acquisition activity, though we believe this is largely reflected in shares at this point.” Ventas closed on Tuesday at $79.39.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorDowngradesAnalyst RatingsJefferies
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!